| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |